Summary
Bausch & Lomb Incorporated (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International, Inc., is a global healthcare company. It develops, manufactures and markets eye health products for a wide range of eye conditions including glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. Bausch & Lomb offers contact lenses, contact lens care, dry eye products, allergy/redness relief, Rx Pharmaceutical, eye vitamins, surgical products, vision accessories and safety and industrial cleaning products. The company has a manufacturing facility in Tampa, Florida, the US. It has a presence in Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.
Bausch & Lomb Incorporated - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Bausch & Lomb Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Bausch & Lomb Incorporated, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Bausch & Lomb Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Bausch & Lomb Incorporated, Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Bausch & Lomb Incorporated, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Bausch & Lomb Incorporated, Medical Equipment, Deal Details 12
Venture Financing 12
AcuFocus Raises Funds Through Series F Financing 12
Partnerships 14
Bausch & Lomb Enters Into Licensing Agreement With Cirle 14
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 15
Bausch & Lomb Enters Into Licensing Agreement With UltraVision 16
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 17
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 18
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 19
Bausch & Lomb Enters Into Distribution Agreement With Technolas Perfect Vision 20
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 21
Equity Offering 22
Bausch & Lomb Withdraws IPO 22
Acquisition 24
Bausch + Lomb to Acquire Doctor's Allergy Formula 24
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 25
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 28
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 30
Bausch & Lomb Acquires Laboratorio Pfortner Cornealent SACIF 32
Bausch & Lomb Incorporated - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 37
Corporate Communications 37
Jul 29, 2015: Bausch + Lomb Announces Appointment of Brian Rosenblatt, OD, to Professional Strategy Team for US Vision Care Business 37
Legal and Regulatory 38
Oct 08, 2015: Robins Kaplan LLP Named Co-Lead Counsel in Disposable Contact Lens Antitrust Litigation 38
Product News 39
Aug 12, 2015: Bausch + Lomb Announces 23-Gauge Fragmentation Needle Availability for Stellaris PC Vision Enhancement System 39
Jan 20, 2015: Bausch + Lomb Introduces New Software and Advanced OCT Imaging System for VICTUS Femtosecond Laser Platform 40
Product Approvals 41
Jan 20, 2015: Bausch + Lomb Introduces New Software and Advanced OCT Imaging System for VICTUS Femtosecond Laser Platform 41
Other Significant Developments 42
May 12, 2016: Bausch + Lomb Named Exclusive U.S. Distributor of HOYA Surgical Optics’ Intraocular Lens and Injector Portfolio 42
Jan 11, 2016: Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source 43
Feb 23, 2015: Bausch + Lomb Announces Strategic Vendor Relationship with Vision Source 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
List Of Tables
List of Tables
Bausch & Lomb Incorporated, Medical Equipment, Key Facts 1
Bausch & Lomb Incorporated, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Bausch & Lomb Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Bausch & Lomb Incorporated, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Bausch & Lomb Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Bausch & Lomb Incorporated, Deals By Market, 2010 to YTD 2016 9
Bausch & Lomb Incorporated, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
AcuFocus Raises Funds Through Series F Financing 12
Bausch & Lomb Enters Into Licensing Agreement With Cirle 14
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 15
Bausch & Lomb Enters Into Licensing Agreement With UltraVision 16
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 17
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 18
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 19
Bausch & Lomb Enters Into Distribution Agreement With Technolas Perfect Vision 20
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 21
Bausch & Lomb Withdraws IPO 22
Bausch + Lomb to Acquire Doctor's Allergy Formula 24
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 25
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 28
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 30
Bausch & Lomb Acquires Laboratorio Pfortner Cornealent SACIF 32
Bausch & Lomb Incorporated, Key Competitors 33
Bausch & Lomb Incorporated, Key Employees 34
Bausch & Lomb Incorporated, Other Locations 35
Bausch & Lomb Incorporated, Subsidiaries 35
List Of Figures
List of Figures
Bausch & Lomb Incorporated, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Bausch & Lomb Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Bausch & Lomb Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Bausch & Lomb Incorporated, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Bausch & Lomb Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Bausch & Lomb Incorporated, Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Bausch & Lomb Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Bausch & Lomb Incorporated, Medical Equipment, Deals by Market, 2010 to YTD 2016 9
